Characteristic of the complete chloroplast genome of Symphoricarpos sinensis, an important ornamental plant endemic to China

por Zhang, Yi, Zhang, Qing Yuan, Ran, Hang, Cao, Yanan
Publicado en Mitochondrial DNA B Resour (2020)

Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis

por Guo, Shan xian, Jian, Yan, Chen, Ying lan, Cai, Yun, Zhang, Qing yuan, Tou, Fang fang
Publicado en Sci Rep (2016)

Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes

por ZHONG, LEI, ZHOU, XING-LU, LIU, YAN-SONG, WANG, YI-MIN, MA, FEI, GUO, BAO-LIANG, YAN, ZHAO-QI, ZHANG, QING-YUAN
Publicado en Mol Med Rep (2015)

Managing Pain in Patients With Cancer: The Chinese Good Pain Management Experience

por Yu, Shi-Ying, Wang, Jie-Jun, Huang, Yu-guang, Hu, Bing, Wang, Kun, Li, Ping Ping, Wu, Yi-Long, Zhang, He-Long, Zhang, Li, Zhang, Qing-Yuan, Qin, Shu-Kui
Publicado en J Glob Oncol (2016)

Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

por Zhao, Shen, Ma, Ding, Xiao, Yi, Li, Xiao‐Mei, Ma, Jian‐Li, Zhang, Han, Xu, Xiao‐Li, Lv, Hong, Jiang, Wen‐Hua, Yang, Wen‐Tao, Jiang, Yi‐Zhou, Zhang, Qing‐Yuan, Shao, Zhi‐Ming
Publicado en Oncologist (2020)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma

por Liu, Lei, Bai, Yu-Xian, Zhou, Jian-Hua, Sun, Xiu-Wei, Sui, Hong, Zhang, Wen-Jie, Yuan, Heng-Heng, Xie, Rui, Wei, Xiao-Li, Zhang, Ting-Ting, Huang, Peng, Li, Yan-Jing, Wang, Jing-Xuan, Zhao, Shu, Zhang, Qing-Yuan
Publicado 2013

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

por Wang, Feng-Hua, Wei, Xiao-Li, Feng, Jifeng, Li, Qi, Xu, Nong, Hu, Xi-Chun, Liao, Wangjun, Jiang, Yi, Lin, Xiao-Yan, Zhang, Qing-yuan, Yuan, Xiang-Lin, Huang, Hai-Xin, Chen, Ye, Dai, Guang-Hai, Shi, Jian-Hua, Shen, Lin, Yang, Shu-Jun, Shu, Yong-Qian, Liu, Yun-Peng, Wang, Weifeng, Wu, Hai, Feng, Hui, Yao, Sheng, Xu, Rui-Hua
Publicado en J Clin Oncol (2021)

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

por Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Costa, Romulo, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, Kanakasetty, G.B., Coccia-Portugal, Maria A., Han, Ru Bing, Lu, Yi, Chi, Hai Dong, Jiang, Ze Fei, Hu, Xi Chun
Publicado en Ther Adv Med Oncol (2020)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

por Johnston, Stephen R. D., Harbeck, Nadia, Hegg, Roberto, Toi, Masakazu, Martin, Miguel, Shao, Zhi Min, Zhang, Qing Yuan, Martinez Rodriguez, Jorge Luis, Campone, Mario, Hamilton, Erika, Sohn, Joohyuk, Guarneri, Valentina, Okada, Morihito, Boyle, Frances, Neven, Patrick, Cortés, Javier, Huober, Jens, Wardley, Andrew, Tolaney, Sara M., Cicin, Irfan, Smith, Ian C., Frenzel, Martin, Headley, Desirée, Wei, Ran, San Antonio, Belen, Hulstijn, Maarten, Cox, Joanne, O’Shaughnessy, Joyce, Rastogi, Priya
Publicado en J Clin Oncol (2020)